Compare NRXS & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NRXS | HNNA |
|---|---|---|
| Founded | 2011 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Investment Managers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.9M | 81.0M |
| IPO Year | 2023 | 2005 |
| Metric | NRXS | HNNA |
|---|---|---|
| Price | $4.44 | $10.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 146.5K | 3.8K |
| Earning Date | 11-09-2026 | 12-02-2026 |
| Dividend Yield | N/A | ★ 6.02% |
| EPS Growth | 22.13 | ★ 38.04 |
| EPS | N/A | ★ 0.73 |
| Revenue | $3,569,282.00 | ★ $54,590,000.00 |
| Revenue This Year | $118.53 | N/A |
| Revenue Next Year | $101.28 | N/A |
| P/E Ratio | ★ N/A | $13.66 |
| Revenue Growth | ★ 32.89 | 3.09 |
| 52 Week Low | $2.50 | $9.20 |
| 52 Week High | $9.33 | $10.89 |
| Indicator | NRXS | HNNA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Hennessy Advisors Inc is an investment management company that manages and markets open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, multi-asset sectors, specialty products, and fixed income products. The company earns revenues mainly from investment advisory services and secondarily from shareholder services. Advisory services include managing each fund's portfolio in line with its investment objectives, monitoring compliance and performance, overseeing sub-advisors and other service providers, and handling marketing, distribution, and regulatory reporting. Shareholder services cover investor support and coordination with the fund service provider, with all related fees based on the funds' average daily net asset values.